Purple Biotech Ltd.PPBTNASDAQ
Loading
Debt to Equity Over TimeFair Value
Percentile Rank45
3Y CAGR-21.6%
5Y CAGR-23.6%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-21.6%/yr
Annual compound
5Y CAGR
-23.6%/yr
Consistent
Percentile
P45
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.01 | -45.7% |
| 2023 | 0.01 | -6.5% |
| 2022 | 0.01 | -5.0% |
| 2021 | 0.01 | +2.5% |
| 2020 | 0.01 | -47.3% |
| 2019 | 0.02 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |